Stem Cell Reserve
Houston, US · Texas limited partnership
Stem Cell Reserve (SCR) operates a hybrid private and public umbilical cord blood and cord tissue biobank, using proprietary methods to store cord products and manufacture cord-derived stem cell and biomatrix products for regenerative medicine. The company serves expectant parents (private banking) and donors (public banking), initially focusing on the Houston Metropolitan Area with plans to expand across major U.S. cities.
Founders & leadership
RM
Raymond MouzannarNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2013
▶$2MraisedMay 2017 · 12 investors · Biotechnology
▶$2MraisedMay 2017 · 12 investors · Biotechnology
Officers, directors & promoters on the filing
- Raymond MouzannarExecutive Officer
- Offering amount
- $5M
- Amount sold
- $2M
- Minimum investment
- $200K
- Proceeds to insiders
- $210K
- First sale
- Nov 2013
- Incorporated
- Limited Partnership, Texas
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Stem Cell Reserve do?
- Stem Cell Reserve (SCR) operates a hybrid private and public umbilical cord blood and cord tissue biobank, using proprietary methods to store cord products and manufacture cord-derived stem cell and biomatrix products for regenerative medicine. The company serves expectant parents (private banking) and donors (public banking), initially focusing on the Houston Metropolitan Area with plans to expand across major U.S. cities.
- How much funding has Stem Cell Reserve raised?
- Stem Cell Reserve has disclosed $2M raised across 1 round.
- Where is Stem Cell Reserve headquartered?
- Stem Cell Reserve is headquartered in Houston, US.